Literature DB >> 17174444

A statistical method for estimating the proportion of cases resulting from cross-transmission of multi-resistant pathogens in an intensive care unit.

R T Mikolajczyk1, U Sagel, R Bornemann, A Krämer, M Kretzschmar.   

Abstract

Multi-resistant bacteria are an increasing challenge for infection control in hospitals and the proportion of patients newly colonized with multi-resistant bacteria during their hospital stay can be used to assess the effectiveness of infection control measures. Current laboratory methods for estimating this require expensive additional tests. We propose an alternative statistical method to estimate the proportion of cases resulting from transmission in a hospital from the distribution of time intervals between subsequent cases. A prerequisite for the application of this method is the existence of records from regular screening of the patients during their hospital stay, usually performed in intensive care units (ICUs). We describe the method and present an example of its application using records of two multi-resistant pathogens collected in an ICU over a three-year period. The estimated proportion of cases resulting from transmission was 0.73 (95% CI: 0.56-0.90) for meticillin-resistant Staphylococcus aureus and 0.45 (95% CI 0.15-0.75) for imipenem-resistant Pseudomonas aeruginosa. The method proposed here can be used for retrospective evaluation of clinical records in order to evaluate the effectiveness of infection control measures in low endemicity settings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174444     DOI: 10.1016/j.jhin.2006.10.005

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  4 in total

1.  Transmission routes of antibiotic resistant bacteria: a systematic review.

Authors:  Noortje G Godijk; Martin C J Bootsma; Marc J M Bonten
Journal:  BMC Infect Dis       Date:  2022-05-20       Impact factor: 3.667

2.  Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients.

Authors:  Antonella Agodi; Martina Barchitta; Rosalba Cipresso; Loredana Giaquinta; Maria Antonietta Romeo; Carmelo Denaro
Journal:  Intensive Care Med       Date:  2007-05-15       Impact factor: 17.440

Review 3.  Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use.

Authors:  Thomas G Slama
Journal:  Crit Care       Date:  2008-10-29       Impact factor: 9.097

4.  Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling study.

Authors:  Gwenan M Knight; Céire Costelloe; Sarah R Deeny; Luke S P Moore; Susan Hopkins; Alan P Johnson; Julie V Robotham; Alison H Holmes
Journal:  BMC Med       Date:  2018-08-23       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.